Literature DB >> 24623843

Prehypertension and the risk of stroke: a meta-analysis.

Yuli Huang1, Xiaoyan Cai, Yingying Li, Liang Su, Weiyi Mai, Sheng Wang, Yunzhao Hu, Yanxian Wu, Dingli Xu.   

Abstract

OBJECTIVE: In this meta-analysis, we sought to evaluate the association between prehypertension and the risk of stroke.
METHODS: We searched PubMed and EMBASE databases for studies with data on prehypertension and stroke. Two independent reviewers assessed the reports and extracted data. Prospective studies were included if they reported multivariate-adjusted relative risks (RRs) with 95% confidence intervals (CIs) for the associations between stroke and prehypertension or its 2 subranges (low-range prehypertension: 120-129/80-84 mm Hg; high-range prehypertension: 130-139/85-89 mm Hg). We conducted subgroup analyses according to blood pressure ranges, stroke type, endpoint, age, sex, ethnicity, and study characteristics.
RESULTS: Pooled data included the results of 762,393 participants from 19 prospective cohort studies. Prehypertension increased the risk of stroke (RR 1.66; 95% CI 1.51-1.81) compared with optimal blood pressure (<120/80 mm Hg). In the secondary outcome analyses, even low-range prehypertension increased the risk of stroke (RR 1.44; 95% CI 1.27-1.63), and the risk was greater for high-range prehypertension (RR 1.95; 95% CI 1.73-2.21). The RR was higher with high-range than with low-range prehypertension (p < 0.001). There were no significant differences in any of the subgroup analyses (all p > 0.05).
CONCLUSIONS: After adjusting for multiple cardiovascular risk factors, prehypertension is associated with stroke morbidity. Although the increased risk is largely driven by high-range prehypertension, the risk is also increased in people with low-range prehypertension.

Entities:  

Mesh:

Year:  2014        PMID: 24623843     DOI: 10.1212/WNL.0000000000000268

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  45 in total

1.  Association of Blood Pressure Classification in Korean Young Adults According to the 2017 American College of Cardiology/American Heart Association Guidelines With Subsequent Cardiovascular Disease Events.

Authors:  Joung Sik Son; Seulggie Choi; Kyuwoong Kim; Sung Min Kim; Daein Choi; Gyeongsil Lee; Su-Min Jeong; Seong Yong Park; Yeon-Yong Kim; Jae-Moon Yun; Sang Min Park
Journal:  JAMA       Date:  2018-11-06       Impact factor: 56.272

2.  Effects of anti-hypertensive treatment on major cardiovascular events in populations within prehypertensive levels: a systematic review and meta-analysis.

Authors:  Zhongqiu Hong; Tao Wu; Shuxian Zhou; Boshui Huang; Jingfeng Wang; Dongmei Jin; Dengfeng Geng
Journal:  J Hum Hypertens       Date:  2018-01-09       Impact factor: 3.012

3.  Hemorheological profiles of subjects with prehypertension.

Authors:  Cesare Tripolino; Agostino Gnasso; Claudio Carallo; Faustina Barbara Scavelli; Concetta Irace
Journal:  Hypertens Res       Date:  2016-02-25       Impact factor: 3.872

4.  Prehypertension or masked hypertension-which is responsible for target-organ damage?

Authors:  Ying Chen; Yu-li Huang; Wei-yi Mai
Journal:  Nat Rev Cardiol       Date:  2015-07-07       Impact factor: 32.419

Review 5.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

6.  Randomised, double-blind, placebo-controlled, assessment of the efficacy and safety of dietary supplements in prehypertension.

Authors:  F Pelliccia; V Pasceri; G Marazzi; A Arrivi; L Cacciotti; G Pannarale; G Speciale; C Greco; C Gaudio
Journal:  J Hum Hypertens       Date:  2017-04-27       Impact factor: 3.012

7.  Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.

Authors:  Paul Muntner; Robert M Carey; Samuel Gidding; Daniel W Jones; Sandra J Taler; Jackson T Wright; Paul K Whelton
Journal:  Circulation       Date:  2017-11-13       Impact factor: 29.690

8.  Potential U.S. Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.

Authors:  Paul Muntner; Robert M Carey; Samuel Gidding; Daniel W Jones; Sandra J Taler; Jackson T Wright; Paul K Whelton
Journal:  J Am Coll Cardiol       Date:  2017-11-13       Impact factor: 24.094

Review 9.  Cardiovascular Risk in Patients with Prehypertension and the Metabolic Syndrome.

Authors:  Sergey Kachur; Rebecca Morera; Alban De Schutter; Carl J Lavie
Journal:  Curr Hypertens Rep       Date:  2018-03-06       Impact factor: 5.369

Review 10.  Prehypertension--prevalence, health risks, and management strategies.

Authors:  Brent M Egan; Sean Stevens-Fabry
Journal:  Nat Rev Cardiol       Date:  2015-02-17       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.